|

VAL-083 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Dianhydrogalactitol

Pipeline

Phase 2/3: 1

Top Sponsors

  • Global Coalition for Adaptive Research1

Indications

  • Glioblastoma1
  • Cancer1

Birmingham, Alabama1 trial

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

University of Alabama at Birmingham

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.